NANJING ANJI BIOLOGICAL TECH CO LTD has a total of 18 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are ESPERANCE PHARMACEUTICALS INC, IGAWA TOMOYUKI and NEXVET AUSTRALIA PTY LTD.
| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 9 | |
| #2 | United States | 5 | |
| #3 | EPO (European Patent Office) | 4 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Xu Hanmei | 11 |
| #2 | Kang Zhian | 7 |
| #3 | Wang Kequan | 3 |
| #4 | Liu Chen | 3 |
| #5 | Zhang Erhao | 2 |